Intestinal Cell News Volume 8.43 | Dec 09 2022

    0
    17







    2022-12-08 | ICN 8.43


    Intestinal Cell News by STEMCELL Technologies
    Vol. 8.43 – 9 December, 2022
    TOP STORY

    B Cell Expansion Hinders the Stroma-Epithelium Regenerative Cross Talk during Mucosal Healing

    To gain insight into the process of mucosal healing, researchers longitudinally examined the immune cell composition during intestinal damage and regeneration.
    [Immunity]

    Full ArticleGraphical AbstractPress Release

    Register now for an on-demand course to culture human intestinal organoids and learn about their downstream applications
    PUBLICATIONSRanked by the impact factor of the journal

    Epithelial TGFβ Engages Growth-Factor Signaling to Circumvent Apoptosis and Drive Intestinal Tumorigenesis with Aggressive Features

    Investigators identified a cohort of born to be bad early-stage colorectal tumours, with aggressive features and a propensity to disseminate early, that were characterized by high epithelial cell-intrinsic TGFβ signaling.
    [Nature Communications]

    Full Article

    HNF4α Acts as Upstream Functional Regulator of Intestinal Wnt3 and Paneth Cell Fate

    Researchers used transcriptomic analyses to dissect the role of HNF4α in the maintenance of jejunal epithelial culture when cultured ex vivo as enteroids, in the presence or absence of compensatory mesenchymal cells.
    [Cellular and Molecular Gastroenterology and Hepatology]

    Abstract

    Bacterial Protein MakA Causes Suppression of Tumour Cell Proliferation via Inhibition of PIP5K1α/Akt Signaling

    The authors evaluated the effects of MakA on the host cell PIP5K1α lipid-signaling pathway and the mechanism by which MakA inhibited cell proliferation and induced cell cycle arrest, particularly in HCT8 colon cancer cells.
    [Cell Death & Disease]

    Full Article

    Artesunate Delays the Dysfunction of Age-Related Intestinal Epithelial Barrier by Mitigating Endoplasmic Reticulum Stress/Unfolded Protein Response

    Investigators demonstrated that the intestinal KIT signaling declined and deactivated with aging, parallel with epithelial barrier dysfunction.
    [Mechanisms of Ageing and Development]

    Full ArticleGraphical Abstract

    The EDN1/EDNRA/β-Arrestin Axis Promotes Colorectal Cancer Progression by Regulating STAT3 Phosphorylation

    Scientists investigated biological functions and novel downstream signaling pathways affected by endothelin receptor A during colorectal progression.
    [International Journal of Oncology]

    Abstract

    Comprehensive microRNA Analysis across Genome-Edited Colorectal Cancer Organoid Models Reveals miR-24 as a Candidate Regulator of Cell Survival

    Using genetically-modified mouse intestinal organoid (enteroid) models, researchers identified 12 different modules of microRNA expression patterns across different combinations of mutations common in colorectal cancer.
    [BMC Genomics]

    Full Article

    Inhibition of Wnt7b Reduces the Proliferation, Invasion, and Migration of Colorectal Cancer Cells

    Investigators explored the effects of Wnt7b regulating the Wnt/β-catenin signaling pathway on the proliferation, migration, and invasion of SW480 cells in colorectal cancer.
    [Molecular Biology Reports]

    Abstract

    The Potential Mechanism of Neu5Gc Inducing Colorectal Cancer Based on Network Pharmacology and Experimental Validation

    Scientists found that Neu5Gc promoted the proliferation of colorectal cancer cells and normal intestinal epithelial cells, and further screened out 98 Neu5Gc targets related to the occurrence and development of colorectal cancer by network pharmacology.
    [Naunyn-Schmiedebergs Archives of Pharmacology]

    Abstract
    ON1093INT-On-demand intestinal training course_728x90
    REVIEWS

    Are Chemical Compounds in Medical Mushrooms Potent against Colorectal Cancer Carcinogenesis and Antimicrobial Growth?

    The authors substantiate the potency of medical mushrooms and their secondary metabolites concerning colon cancer carcinogenesis and antimicrobial growth.
    [Cancer Cell International]

    Full Article
    INDUSTRY AND POLICY NEWS

    Sosei Heptares Enters R&D Agreements with the University of Oxford and KU Leuven to Identify and Validate Key GPCRs Driving Gastrointestinal and Immune Disorders

    Sosei Group Corporation announced it had entered translational medicine and R&D agreements with the MRC Weatherall Institute of Molecular Medicine at the University of Oxford, UK and KU Leuven, Belgium.
    [Sosei Group Corporation]

    Press Release
    FEATURED EVENT

    DDR Inhibitors Summit 2023

    January 24 – 26, 2023
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Liver Metastasis of Colorectal Cancer

    Karolinska Institute – Solna, Sweden

    Postdoctoral Scientist – Genomic Informatics

    University of Oxford – Oxford, England, United Kingdom

    Postdoctoral Research Associate – Stem Cells and Regeneration

    University of Bristol – Bristol, England, United Kingdom

    Postdoctoral Research Associate – Intestinal Inflammation and Regeneration

    University of Illinois Chicago – Chicago, Illinois, United States

    Senior Program Associate – Science in the City

    STEMCELL Technologies, Inc. – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter